About
Tony Ho previously served as Executive Vice President and Head of Research and Development at CRISPR Therapeutics, where he built an R&D pipeline that advanced multiple candidates into the clinic, including CTX001 and several allogeneic CAR-T programs. Before that, he held senior roles at AstraZeneca overseeing oncology programs such as Lynparza and Imfinzi, led Neurology and Ophthalmology at Merck, and co-founded Neuronyx as its CSO. He holds a B.S. in Electrical Engineering from UCLA and an M.D. from Johns Hopkins, and holds academic appointments in neurology at the University of Pennsylvania and Johns Hopkins.
Invests in
BiotechHealthtechMedical Devices
Experience
- Pivotal LifesciencesChief Scientific Officer & Senior Science Partnercurrent2022 — presentBoston, Massachusetts, United States
- Self-employedBiotech Entrepreneurcurrent2022 — presentBoston, Massachusetts, United States
- CRISPR TherapeuticsExecutive Vice President and Head of Research and Development2017 — 2021Greater Boston Area
- AstraZenecaHead of Oncology Innovation and Integration, Senior Vice President2012 — 2017Washington D.C. Metro Area
- AstraZenecaGlobal Medicine Leader Imfinzi (Durvalumab/MEDI4736), Vice President Immuno-Oncology2012 — 2017
- AstraZenecaGlobal Product Vice President, Olaparib, Oncology GMED2012 — 2015United States
- AstraZenecaVice President, Clinical Innovative Medicine- New Opportunities2012 — 2013
- Merck & Co., Inc.Neurology & Ophthalmology Section Head/ Executive Director2003 — 2011
- Merck & Co., Inc.Senior Director Clinical Neuroscience and Ophthalmology2007 — 2010
- NeuronyxCo-founder, Chief Scientific Officer, Senior Vice President of R & D2000 — 2003
- Johns Hopkins UniversityAssistant Professor of Neurology1997 — 2000
- Johns Hopkins HospitalNeurology Residency & Fellowship1992 — 1997
- Massachusetts General HospitalInternship1991 — 1992
Skills & more
CTMS14Neuroscience99Medicine23Clinical Development99Clinical Research66Clinical Trials31Drug Development99Neurology56Innovation5Parkinson's5Ophthalmology7Migraine4
+12 more
BiotechnologyPharmaceutical IndustryDrug DiscoveryGCPNeuropathic PainStrokeAlzheimer's diseaseGlaucomaDry EyeBusiness DevelopmentOsteoporosisNeurodegenerative DiseaseFrom Tony's professional profile.
Colleagues at Pivotal Life Sciences
AJ Velasquez-Mao
Associate at Dolby Family Ventures
Ash Khanna
Partner at Pivotal bioVenture Partners
Benjamin Li
Vice President at Pivotal Life Sciences
Brian Mills
Vice President at Pivotal Life Sciences
Glenn Batchelder
Venture Partner at Pivotal Life Sciences
Jeni Lee
Partner at Pivotal Life Sciences
Lisa Marrone
Investor at Pivotal bioVenture Partners
Peter Bisgaard
Managing Director at Pivotal Life Sciences
Frequently asked questions
- Who is Tony Ho?
- Tony Ho previously served as Executive Vice President and Head of Research and Development at CRISPR Therapeutics, where he built an R&D pipeline that advanced multiple candidates into the clinic, including CTX001 and several allogeneic CAR-T programs. Before that, he held senior roles at AstraZeneca overseeing oncology programs such as Lynparza and Imfinzi, led Neurology and Ophthalmology at Merck, and co-founded Neuronyx as its CSO. He holds a B.S. in Electrical Engineering from UCLA and an M.D. from Johns Hopkins, and holds academic appointments in neurology at the University of Pennsylvania and Johns Hopkins.
- Where does Tony Ho work?
- Tony Ho is at Pivotal Life Sciences.
- What does Tony Ho invest in?
- Tony Ho invests in Biotech, Healthtech, Medical Devices.
- Where did Tony Ho go to school?
- Tony Ho studied at The Johns Hopkins University School of Medicine (M.D., Medicine); UCLA (B. S., Electrical Engineering); Katella High School.
Same school
Also attended The Johns Hopkins University School of Medicine28
Hal PazInvestor at Khosla VenturesRochelle WalenskyExecutive Partner at Flare Capital PartnersBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersS.K. LeeExecutive Coach at Roble VenturesKayarash KarimianSenior Associate at Cure VenturesSamantha GuinnAnalyst at Novartis Venture Fund
.png)
+ 22 more
Also attended UCLA499
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzRon ConwayFounder of SV AngelKirsten GreenFounder and Managing Partner at Forerunner VenturesVlad TenevCo-founder & CEO of RobinhoodRyan KingCo-founder of ChimePaul FieldingFinance & Operations at General Catalyst
+ 493 more
Shared employers
Also worked at CRISPR Therapeutics6
Briggs MorrisonEntrepreneur Partner at MPM BioImpactJerel DavisManaging Director at Versant VenturesJohn LeonardExecutives in Residence at GENERAL INCEPTIONKurt von EmsterManaging Partner at AbingworthMaria FardisVenture Partner at Frazier Life SciencesRodger NovakVenture Partner at SR One Capital Management
Also worked at AstraZeneca60
Detlev BiniszkiewiczManaging Director at MPM BioImpactBriggs MorrisonEntrepreneur Partner at MPM BioImpactJung Lee, PhDVenture Partner at Adelphi Ventures Management, LlcJohan LundVenture Partner at ScietyAnnie VemuSenior Associate at Longwood FundIliam BarkinoInvestor at Industrifonden
+ 54 more
Also worked at Merck & Co., Inc.106
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesAndrea van ElsasInvestor at Third Rock Ventures
+ 100 more
Also worked at Johns Hopkins University57
Demi ObayomiPrincipal at Sapphire VenturesJun JeonInvestor at Khosla VenturesLinda CuretonBoard Member at Maryland TEDCODavid NarrowVenture Advisor at Cultivation CapitalCharlie BuffaVice President, Sales at Mainsail PartnersOluwakayode (Kay) JasanyaInvestor at SUPPLY CHANGE CAPITAL
+ 51 more